Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Yiling, Yu"'
Autor:
Haitao Wang, Xinfeng Hou, Wenjing Zhang, Yiwen Wang, Lin LI, Yang LI, Bruce Luweihing, Min XI, Jiayun Song, Xinxin Zhu, Liyun Zhou, Xiangmei Chen, Yiling Yu, Wei Jin, Zhirong Shen
Publikováno v:
HemaSphere, Vol 7, p e24358c2 (2023)
Externí odkaz:
https://doaj.org/article/71dd65f027064548961e7c43907eefcc
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Dupilumab was the first biological medication licensed to treat atopic dermatitis (AD), and it has shown remarkable effectiveness and safety in the treatment of moderate-to-severe atopic dermatitis. There are limited drug-related adverse events assoc
Externí odkaz:
https://doaj.org/article/94d2f82896894eca82b30cc746af3eee
Autor:
Binghui Jin, Yiling Yu, Chenghao Lou, Xiaodi Zhang, Bowen Gong, Jinghao Chen, Xiangxiang Chen, Zihan Zhou, Liqun Zhang, Jian Xiao, Jiajia Xue
Publikováno v:
Advanced Science, Vol 10, Iss 4, Pp n/a-n/a (2023)
Abstract Peripheral nerve injury is a serious medical problem with limited surgical and clinical treatment options. It is of great significance to integrate multiple guidance cues in one platform of nerve guidance conduits (NGCs) to promote axonal el
Externí odkaz:
https://doaj.org/article/0c9ded6c9e334d24af167dc6cc7b0a01
Autor:
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Tingyu Wang, Dengju Li, Meng Ji, Haiyi Guo, Xia Zhao, Binghao Wu, Yiling Yu, Yu Wang, Jane Huang, William Novotny, Jianyong Li
Publikováno v:
Leukemia & Lymphoma. 64:712-716
Autor:
Yiling Yu1,2, Volodymyr Turkowski3, Hachtel, Jordan A.1, Puretzky, Alexander A.1, Ievlev, Anton V.1, Din, Naseem U.3, Harris, Sumner B.1, Iyer, Vasudevan1, Rouleau, Christopher M.1, Rahman, Talat S.3, Geohegan, David B.1, Kai Xiao1 xiaok@ornl.gov
Publikováno v:
Science Advances. 2/23/2024, Vol. 10 Issue 8, p1-9. 9p.
Autor:
Yiyi Gu, Lizhi Zhang, Hui Cai, Liangbo Liang, Chenze Liu, Anna Hoffman, Yiling Yu, Austin Houston, Alexander A. Puretzky, Gerd Duscher, Philip D. Rack, Christopher M. Rouleau, Xiangmin Meng, Mina Yoon, David B. Geohegan, Kai Xiao
Publikováno v:
ACS Nano. 16:13900-13910
Autor:
Matthew G. Boebinger, Courtney Brea, Li‐Ping Ding, Sudhajit Misra, Olugbenga Olunloyo, Yiling Yu, Kai Xiao, Andrew R. Lupini, Feng Ding, Guoxiang Hu, Panchapakesan Ganesh, Stephen Jesse, Raymond R. Unocic
Publikováno v:
Advanced Materials. 35
Autor:
Gang An, Chenmu Du, Shu Cheng, Jianfeng Zhou, Binghao Wu, Haiyi Guo, Lingzhi Yan, Liye Zhong, Yiling Yu, Jie Jin, Liping Xie, Jinhua Zhong, Daobin Zhou, Jianyong Li, Keshu Zhou, Lugui Qiu
Publikováno v:
Clinical Cancer Research. 27:5492-5501
Purpose: Although Bruton tyrosine kinase (BTK) inhibitors have demonstrated promising efficacy in patients with Waldenström macroglobulinemia (WM), data in Asian populations are scarce. This trial is the first to investigate the effect of a BTK inhi
Autor:
Yan, Zeng, Wei, Dai, Rundong, Ma, Zhe, Li, Zhenwei, Ou, Cheng, Wang, Yiling, Yu, Tong, Zhu, Xiaoze, Liu, Ti, Wang, Hongxing, Xu
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 18(44)
Van der Waals semiconducting heterostructures, known as stacks of atomically thin transition-metal dichalcogenide (TMD) layers, have recently been reported as new quantum materials with fascinating optoelectronic properties and novel functionalities.
Autor:
Christopher M. Rouleau, Gyula Eres, Matthew F. Chisholm, Alexander A. Puretzky, David B. Geohegan, Mina Yoon, Kai Xiao, Yiling Yu, Chenze Liu, Yu-Chuan Lin, Gerd Duscher
Publikováno v:
ACS Nano. 15:8638-8652
Understanding the bottom-up synthesis of atomically thin two-dimensional (2D) crystals and heterostructures is important for the development of new processing strategies to assemble 2D heterostructures with desired functional properties. Here, we uti